ENACT-aMCI: ENgaging in Advance Care Planning Talks Group Visit Intervention for Cognitive Impairment
Study Details
Study Description
Brief Summary
The Advance Care Planning Group Visit intervention is a new intervention that uses the strengths of group visits to promote advance care planning conversations and documentation. However, the Advance Care Planning Group Visit intervention was initially designed for individuals without cognitive impairment. This study will specifically investigate ways to adapt the Advance Care Planning Group Visit intervention for individuals with amnestic Mild Cognitive Impairment and their family care partners.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Advance care planning is a process that supports adults at any age or stage of health in understanding and sharing their personal values, life goals, and preferences regarding future medical care. The goal of advance care planning is to help ensure that people receive medical care that is consistent with their values, goals and preferences during serious and chronic illness.
The Advance Care Planning Group Visit intervention is a new intervention that uses the strengths of group visits to promote advance care planning conversations and documentation. However, the Advance Care Planning Group Visit intervention was initially designed for individuals without cognitive impairment. This study will specifically investigate ways to adapt the Advance Care Planning Group Visit intervention for individuals with amnestic Mild Cognitive Impairment.
This is a pilot test of the Advance Care Planning Group Visit intervention adaptations, called ENgaging in Advance Care planning Talks Group Visit intervention (ENACT Memory Group Visits), to see if it is feasible, acceptable and improves the number of people with amnestic mild cognitive impairment who complete an advance directive (a legal form that describes someone's wishes for future medical care if they are unable to make their own decisions). It will also see how ready individuals are to participate in advance care planning. The overall goal is to improve opportunities for older adults with amnestic mild cognitive impairment to receive medical care that is consistent with their values, goals, and preferences.
This aim will use rapid-cycle prototyping (n-of-1 interventions) to conduct the ENgaging in Advance Care planning Talks (ENACT) Memory Group Visits, adapting them for individuals with amnestic Mild Cognitive Impairment. Each n-of-1 prototype will include up to 10 patient-study partner dyads meeting in up to two 2-hour group medical visit sessions, one month apart. Four cohorts will be conducted so that approximately 40 participants are involved in the n-of-1 prototypes of the ENACT Memory Group Visit intervention. The intervention will be conducted based on an intervention manual that will be refined and adapted with input from patients, study partners, and the research team of multidisciplinary clinicians. Participants will receive the Colorado Medical Durable Power of Attorney form and other appropriate advance care planning resources for individuals with aMCI.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Advance Care Planning Group Visits - amnestic Mild Cognitive Impairment Participants with amnestic Mild Cognitive Impairment will attend group visits to discuss advance care planning with their study partners. Group visits will last up to two hours and be help up to twice. |
Behavioral: Advance Care Planning Group Visits
Pilot test the Advance Care Planning Group Visit intervention adaptations, called ENgaging in Advance Care planning Talks Group Visit intervention (ENACT Memory Group Visits), to see if it is feasible, acceptable and improves the number of people with amnestic mild cognitive impairment who complete an advance directive (a legal form that describes someone's wishes for future medical care if they are unable to make their own decisions). It will also see how ready individuals are to participate in advance care planning. The overall goal is to improve opportunities for older adults with amnestic mild cognitive impairment to receive medical care that is consistent with their values, goals, and preferences.
|
Experimental: Advance Care Planning Group Visits - Care Partners Care partners of persons with amnestic Mild Cognitive Impairment will attend group visits, with the person with Mild Cognitive Impairment, to discuss advance care planning. Group visits will last up to two hours and be help up to twice. |
Behavioral: Advance Care Planning Group Visits
Pilot test the Advance Care Planning Group Visit intervention adaptations, called ENgaging in Advance Care planning Talks Group Visit intervention (ENACT Memory Group Visits), to see if it is feasible, acceptable and improves the number of people with amnestic mild cognitive impairment who complete an advance directive (a legal form that describes someone's wishes for future medical care if they are unable to make their own decisions). It will also see how ready individuals are to participate in advance care planning. The overall goal is to improve opportunities for older adults with amnestic mild cognitive impairment to receive medical care that is consistent with their values, goals, and preferences.
|
Outcome Measures
Primary Outcome Measures
- Change in Readiness to Engage in ACP (ACP Engagement Scale) [0, 3 months]
The Advance Care Planning (ACP) Engagement Scale will be used to assess readiness to engage in specific parts of the advance care planning process (i.e. signing official papers to name a medical decision maker; talking to the decision maker; talking to the doctor; signing official papers putting their wishes in writing). Items are rated on a Likert scale, with possible scores ranging from 1-5. Higher scores indicate a higher level of engagement with the advance care planning behavior and a better outcome.
Secondary Outcome Measures
- Change in Readiness to Engage in ACP (ACP Engagement Score) - Care Partner Reported [0, 3 months]
Care partner report of the Advance Care Planning (ACP) Engagement Scale will be used to assess care partner perspectives on the person with amnestic mild cognitive impairment's readiness to engage in specific parts of the advance care planning process (i.e. signing official papers to name a medical decision maker; talking to the decision maker; talking to the doctor; signing official papers putting their wishes in writing). Items are rated on a Likert scale, with possible scores ranging from 1-5. Higher scores indicate a higher level of engagement with the advance care planning behavior and a better outcome.
Other Outcome Measures
- Advance Care Planning Intervention Evaluation [Following Session Participation, 15 minutes after completed]
Investigator-developed 7-item evaluation to assess participant rating of intervention comfort in the group setting, usefulness, preference compared to one-on-one visits, and helpfulness of talking with others. Each item is rated from "strong disagree" to "strongly agree" on a 5-point Likert scale. Scores can range from 1-5 with a score of 5 being a better outcome. This scale has not been specifically named. It has been published in the included reference.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
diagnosis of amnestic mild cognitive impairment
-
ability to provide consent
-
have a study partner who has regular interaction with the patient
Exclusion Criteria:
-
known prior diagnosis of deafness/hearing loss that would limit group discussion participation
-
inability to travel to study location
-
not having access to a phone for follow up
-
not having an individual who is able to serve as a study partner to the patient
-
normal cognitive screen based on SPMSQ
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | UCHealth | Aurora | Colorado | United States | 80045 |
2 | University of Colorado Anschutz Medical Campus | Aurora | Colorado | United States | 80045 |
Sponsors and Collaborators
- University of Colorado, Denver
Investigators
None specified.Study Documents (Full-Text)
More Information
Publications
- Lum HD, Dukes J, Daddato AE, Juarez-Colunga E, Shanbhag P, Kutner JS, Levy CR, Sudore RL. Effectiveness of Advance Care Planning Group Visits Among Older Adults in Primary Care. J Am Geriatr Soc. 2020 Oct;68(10):2382-2389. doi: 10.1111/jgs.16694. Epub 2020 Jul 29.
- Lum HD, Jones J, Matlock DD, Glasgow RE, Lobo I, Levy CR, Schwartz RS, Sudore RL, Kutner JS. Advance Care Planning Meets Group Medical Visits: The Feasibility of Promoting Conversations. Ann Fam Med. 2016 Mar;14(2):125-32. doi: 10.1370/afm.1906.
- Lum HD, Sudore RL, Matlock DD, Juarez-Colunga E, Jones J, Nowels M, Schwartz RS, Kutner JS, Levy CR. A Group Visit Initiative Improves Advance Care Planning Documentation among Older Adults in Primary Care. J Am Board Fam Med. 2017 Jul-Aug;30(4):480-490. doi: 10.3122/jabfm.2017.04.170036.
- 18-1459
Study Results
Participant Flow
Recruitment Details | |
---|---|
Pre-assignment Detail |
Arm/Group Title | Advance Care Planning Group Visits - aMCI | Advance Care Planning Group Visits - Care Partners |
---|---|---|
Arm/Group Description | Participants with amnestic mild cognitive impairment (aMCI) will attend group visits to discuss advance care planning with their study partners. Group visits will last up to two hours and be held up to twice. | Participants who are the care partners of persons with amnestic mild cognitive impairment (aMCI) will attend group visits (with the person with aMCI) to discuss advance care planning with their study partners. Group visits will last up to two hours and be held up to twice. |
Period Title: Overall Study | ||
STARTED | 13 | 13 |
COMPLETED | 13 | 13 |
NOT COMPLETED | 0 | 0 |
Baseline Characteristics
Arm/Group Title | Intervention |
---|---|
Arm/Group Description | Participants attended two group visits one month apart to discuss advance care planning and to receive information about advance care planning. |
Overall Participants | 13 |
Age (Count of Participants) | |
<=18 years |
0
0%
|
Between 18 and 65 years |
0
0%
|
>=65 years |
13
100%
|
Age (years) [Mean (Standard Deviation) ] | |
Mean (Standard Deviation) [years] |
78.7
(5.8)
|
Sex: Female, Male (Count of Participants) | |
Female |
3
23.1%
|
Male |
10
76.9%
|
Ethnicity (NIH/OMB) (Count of Participants) | |
Hispanic or Latino |
1
7.7%
|
Not Hispanic or Latino |
12
92.3%
|
Unknown or Not Reported |
0
0%
|
Race (NIH/OMB) (Count of Participants) | |
American Indian or Alaska Native |
0
0%
|
Asian |
0
0%
|
Native Hawaiian or Other Pacific Islander |
0
0%
|
Black or African American |
1
7.7%
|
White |
10
76.9%
|
More than one race |
0
0%
|
Unknown or Not Reported |
2
15.4%
|
Region of Enrollment (Count of Participants) | |
United States |
13
100%
|
Education (Count of Participants) | |
High School Graduate |
3
23.1%
|
Some College |
1
7.7%
|
College Graduate |
2
15.4%
|
Any Post-graduate |
7
53.8%
|
Relationship status (Count of Participants) | |
Married/with partner |
10
76.9%
|
Widowed |
1
7.7%
|
Divorced/separated |
2
15.4%
|
Caregiver in the last 12 months (Count of Participants) | |
Yes |
2
15.4%
|
No |
11
84.6%
|
Self-Rated Health (Count of Participants) | |
Excellent |
8
61.5%
|
Good |
3
23.1%
|
Fair |
2
15.4%
|
Poor |
0
0%
|
Very Poor |
0
0%
|
Relationship of Study Partner to Participant (Count of Participants) | |
Spouse |
9
69.2%
|
Partner |
1
7.7%
|
Child |
3
23.1%
|
Outcome Measures
Title | Change in Readiness to Engage in ACP (ACP Engagement Scale) |
---|---|
Description | The Advance Care Planning (ACP) Engagement Scale will be used to assess readiness to engage in specific parts of the advance care planning process (i.e. signing official papers to name a medical decision maker; talking to the decision maker; talking to the doctor; signing official papers putting their wishes in writing). Items are rated on a Likert scale, with possible scores ranging from 1-5. Higher scores indicate a higher level of engagement with the advance care planning behavior and a better outcome. |
Time Frame | 0, 3 months |
Outcome Measure Data
Analysis Population Description |
---|
Participants with aMCI |
Arm/Group Title | Advance Care Planning Group Visits - Persons With aMCI |
---|---|
Arm/Group Description | Participants with amnestic Mild Cognitive Impairment will attend group visits to discuss advance care planning with their study partners. Group visits will last up to two hours and be help up to twice. |
Measure Participants | 13 |
Readiness to sign official papers naming a medical decision maker at 0 months |
1.92
(1.12)
|
Readiness to talk to decision maker at 0 months |
1.54
(0.88)
|
Readiness to talk to doctor at 0 months |
2.77
(1.36)
|
Readiness to sign papers putting wishes into writing at 0 months |
2.00
(1.15)
|
Readiness to sign official papers naming a medical decision maker at 3 months |
1.77
(0.93)
|
Readiness to talk to decision maker at 3 months |
2.38
(0.96)
|
Readiness to talk to doctor at 3 months |
2.00
(0.91)
|
Readiness to sign papers putting wishes into writing at 3 months |
2.08
(1.16)
|
Title | Change in Readiness to Engage in ACP (ACP Engagement Score) - Care Partner Reported |
---|---|
Description | Care partner report of the Advance Care Planning (ACP) Engagement Scale will be used to assess care partner perspectives on the person with amnestic mild cognitive impairment's readiness to engage in specific parts of the advance care planning process (i.e. signing official papers to name a medical decision maker; talking to the decision maker; talking to the doctor; signing official papers putting their wishes in writing). Items are rated on a Likert scale, with possible scores ranging from 1-5. Higher scores indicate a higher level of engagement with the advance care planning behavior and a better outcome. |
Time Frame | 0, 3 months |
Outcome Measure Data
Analysis Population Description |
---|
Care partners of persons with aMCI |
Arm/Group Title | Advance Care Planning Group Visits - Care Partners |
---|---|
Arm/Group Description | Care partners of persons with amnestic mild cognitive impairment who participated in the advance care planning group visits. |
Measure Participants | 13 |
Readiness to sign official papers naming a medical decision maker at 0 months |
1.92
(1.19)
|
Readiness to talk to decision maker at 0 months |
2.31
(1.25)
|
Readiness to talk to doctor at 0 months |
2.62
(0.96)
|
Readiness to sign papers putting wishes into writing at 0 months |
1.62
(0.77)
|
Readiness to sign official papers naming a medical decision maker at 3 months |
1.69
(1.11)
|
Readiness to talk to decision maker at 3 months |
2.54
(0.88)
|
Readiness to talk to doctor at 3 months |
1.77
(.93)
|
Readiness to sign papers putting wishes into writing at 3 months |
1.92
(0.95)
|
Title | Advance Care Planning Intervention Evaluation |
---|---|
Description | Investigator-developed 7-item evaluation to assess participant rating of intervention comfort in the group setting, usefulness, preference compared to one-on-one visits, and helpfulness of talking with others. Each item is rated from "strong disagree" to "strongly agree" on a 5-point Likert scale. Scores can range from 1-5 with a score of 5 being a better outcome. This scale has not been specifically named. It has been published in the included reference. |
Time Frame | Following Session Participation, 15 minutes after completed |
Outcome Measure Data
Analysis Population Description |
---|
Combined persons with aMCI and care partners groups |
Arm/Group Title | Advance Care Planning Group Visits - Amnestic Mild Cognitive Impairment | Advance Care Planning Group Visits - Care Partners |
---|---|---|
Arm/Group Description | Participants with aMCI completed an evaluation of the intervention prototype. | Care partners of persons with amnestic Mild Cognitive Impairment who participated in the advance care planning group visits. |
Measure Participants | 13 | 13 |
Group setting is better for ACP discussion than normal doctor visit |
4.23
(1.09)
|
4.69
(0.48)
|
The group discussion gave me useful information |
4.62
(0.51)
|
5.00
(0.00)
|
I felt comfortable talking about ACP in the group setting |
4.54
(0.66)
|
4.92
(0.28)
|
Talking with other people about ACP was helpful |
4.23
(1.36)
|
5.00
(0.00)
|
I feel the group visit addressed my specific questions |
4.31
(0.75)
|
4.46
(0.66)
|
I feel able to discuss ACP with my regular healthcare provider |
4.62
(0.51)
|
4.38
(0.65)
|
I would recommend these group visit sessions to a friend |
4.38
(1.45)
|
4.92
(0.28)
|
Adverse Events
Time Frame | 3 months | |
---|---|---|
Adverse Event Reporting Description | ||
Arm/Group Title | Advance Care Planning Group Visits | |
Arm/Group Description | Participants will attend group visits to discuss advance care planning with their study partners. Group visits will last up to two hours and be help up to twice. Advance Care Planning Group Visit: Aim 1: The first part of this study will focus on refining and adapting the Advance Care Planning Group Visit intervention so that it meets the needs of persons with amnestic cognitive impairment and a study partner who participates with them. Aim 2: The second part of the study will pilot test the Advance Care Planning Group Visit intervention adaptations, called ENgaging in Advance Care planning Talks Group Visit intervention (ENACT Memory Group Visits), to see if it is feasible, acceptable and improves the number of people with amnestic mild cognitive impairment who complete an advance directive (a legal form that describes someone's wishes for future medical care if they are unable to make their own decisions). It will also see how ready individuals are to participate in advance care planning. The overall goal is to improve opportunities for older adults with amnestic mild cognitive impairment to receive medical care that is consistent with their values, goals, and preferences. | |
All Cause Mortality |
||
Advance Care Planning Group Visits | ||
Affected / at Risk (%) | # Events | |
Total | 0/13 (0%) | |
Serious Adverse Events |
||
Advance Care Planning Group Visits | ||
Affected / at Risk (%) | # Events | |
Total | 0/13 (0%) | |
Other (Not Including Serious) Adverse Events |
||
Advance Care Planning Group Visits | ||
Affected / at Risk (%) | # Events | |
Total | 0/13 (0%) |
Limitations/Caveats
More Information
Certain Agreements
All Principal Investigators ARE employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
Results Point of Contact
Name/Title | Dr. Hillary D. Lum |
---|---|
Organization | University of Colorado School of Medicine |
Phone | 303-724-1911 |
hillary.lum@cuanschutz.edu |
- 18-1459